Chen S - Search Results

1

CD20-positive extranodal NK/T cell lymphoma: clinicopathologic and prognostic features.

Huang Y, Chen S, Wei R, Guo X, Yang X, Cao Q, Yang Y, Yun J. Huang Y, et al. Among authors: chen s. Virchows Arch. 2020 Dec;477(6):873-883. doi: 10.1007/s00428-020-02776-x. Epub 2020 Apr 20. Virchows Arch. 2020. PMID: 32314054 Review.

2

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma.

Fu J, Li M, Wu DC, Liu LL, Chen SL, Yun JP. Fu J, et al. Transl Oncol. 2015 Oct;8(5):400-406. doi: 10.1016/j.tranon.2015.08.003. Transl Oncol. 2015. PMID: 26500030 Free PMC article.

3

HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.

Chen SL, Liu LL, Lu SX, Luo RZ, Wang CH, Wang H, Cai SH, Yang X, Xie D, Zhang CZ, Yun JP. Chen SL, et al. Mol Oncol. 2017 Sep;11(9):1225-1240. doi: 10.1002/1878-0261.12090. Epub 2017 Jul 11. Mol Oncol. 2017. PMID: 28580773 Free PMC article.

4

CBX8 Exhibits Oncogenic Activity via AKT/β-Catenin Activation in Hepatocellular Carcinoma.

Zhang CZ, Chen SL, Wang CH, He YF, Yang X, Xie D, Yun JP. Zhang CZ, et al. Cancer Res. 2018 Jan 1;78(1):51-63. doi: 10.1158/0008-5472.CAN-17-0700. Epub 2017 Oct 24. Cancer Res. 2018. PMID: 29066512

5

eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.

Chen SL, Lu SX, Liu LL, Wang CH, Yang X, Zhang ZY, Zhang HZ, Yun JP. Chen SL, et al. Transl Oncol. 2018 Feb;11(1):125-131. doi: 10.1016/j.tranon.2017.11.001. Epub 2017 Dec 18. Transl Oncol. 2018. PMID: 29248802 Free PMC article.

6

POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim.

Wang CH, Lu SX, Liu LL, Li Y, Yang X, He YF, Chen SL, Cai SH, Wang H, Yun JP. Wang CH, et al. Neoplasia. 2018 May;20(5):411-424. doi: 10.1016/j.neo.2018.02.005. Epub 2018 Mar 21. Neoplasia. 2018. PMID: 29573636 Free PMC article.

7

A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway.

Wang H, Zhang CZ, Lu SX, Zhang MF, Liu LL, Luo RZ, Yang X, Wang CH, Chen SL, He YF, Xie D, Xu RH, Yun JP. Wang H, et al. Hepatology. 2019 Jan;69(1):179-195. doi: 10.1002/hep.30147. Epub 2018 Dec 22. Hepatology. 2019. PMID: 30028541

8

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

Wang CH, Liu LL, Liao DZ, Zhang MF, Fu J, Lu SX, Chen SL, Wang H, Cai SH, Zhang CZ, Zhang HZ, Yun JP. Wang CH, et al. Cancer Manag Res. 2018 Jul 25;10:2241-2248. doi: 10.2147/CMAR.S166789. eCollection 2018. Cancer Manag Res. 2018. PMID: 30100755 Free PMC article.

9

A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.

Chen SL, Zhang CZ, Liu LL, Lu SX, Pan YH, Wang CH, He YF, Lin CS, Yang X, Xie D, Yun JP. Chen SL, et al. Cancer Res. 2019 Feb 1;79(3):534-545. doi: 10.1158/0008-5472.CAN-18-2357. Epub 2018 Dec 24. Cancer Res. 2019. PMID: 30584071

10

Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.

Chen SL, Liu LL, Wang CH, Lu SX, Yang X, He YF, Zhang CZ, Yun JP. Chen SL, et al. Mol Oncol. 2020 Feb;14(2):373-386. doi: 10.1002/1878-0261.12593. Epub 2019 Dec 19. Mol Oncol. 2020. PMID: 31670863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87,805 results

Search Page

Filters